From: Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac
Region of interest | Criteria | Region of interest | Criteria |
---|---|---|---|
aPTV | Stomach | ||
b\(\:{\text{V}}_{100\%\left(50\text{G}\text{y}\right)\:}\) | ≥ 95% | \({}^{\rm{c}}{{\rm{D}}_{{\rm{max}}\>\left( {0.5{\rm{cc}}} \right)}}\) | < 32 Gy |
b\(\:{\text{V}}_{95\%\:\left(47.5\text{G}\text{y}\right)}\) | ≥ 99% | c\(\:{\text{D}}_{10\text{c}\text{c}\:}\) | < 18 Gy |
c\(\:{\text{D}}_{\text{m}\text{a}\text{x}\:\left(0.5\text{c}\text{c}\right)}\) | (110%∼140%)Dpre; (55 Gy ∼ 70 Gy) | Rib | |
d\(\:{\text{D}}_{\text{m}\text{i}\text{n}\:}\) | ≥ 90%\(\:{\text{D}}_{\text{p}\text{r}\text{e}\:}\)(45 Gy) | c\(\:{\text{D}}_{\text{m}\text{a}\text{x}\:}\) | < 43 Gy |
Liver minus GTV | c\(\:{\text{D}}_{1\text{c}\text{c}\:}\) | < 35 Gy | |
e\(\:{\text{D}}_{700\text{c}\text{c}\:}\) | <18 Gy | Kidney | |
f\(\:{\text{D}}_{30\%\:}\) | < 18 Gy | g\(\:{\text{V}}_{10\text{G}\text{y}\:}\) | < 10% |
Spinal cord | h\(\:{\text{D}}_{\text{m}\text{e}\text{a}\text{n}\:}\) | < 10 Gy | |
c\(\:{\text{D}}_{\text{m}\text{a}\text{x}\:}\) | < 30 Gy | Small bowel | |
e\(\:{\text{D}}_{0.35\text{c}\text{c}}\) | < 23 Gy | \({}^{\rm{c}}{{\rm{D}}_{{\rm{max}}\>\left( {0.5{\rm{cc}}} \right)}}\) | < 30 Gy |
e\(\:{\text{D}}_{1.2\text{c}\text{c}\:}\) | < 14 Gy | e\(\:{\text{D}}_{15\text{c}\text{c}\:}\) | < 19.5 Gy |
Heart | Duodenum | ||
c\(\:{\text{D}}_{0.5\text{c}\text{c}}\) | < 27 Gy | c\(\:{\text{D}}_{5\text{c}\text{c}\:}\) | < 18 Gy |
Lung right and left | c\(\:{\text{D}}_{10\text{c}\text{c}}\) | < 12 Gy | |
e\(\:{\text{D}}_{1000\text{c}\text{c}}\) | < 13.5 Gy | Esophagus | |
e\(\:{\text{D}}_{1500\text{c}\text{c}}\) | < 12.5 Gy | c\(\:{\text{D}}_{5\text{c}\text{c}\:}\) | < 19.5 Gy |